You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

apg-2575

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma, Solid Tumor Trial (APG-115, APG-2575)

Not yet recruiting
  • Neuroblastoma
  • Solid Tumor
  • (no location specified)
Jan 18, 2023

Breast Cancer, Solid Tumor, Adult Trial in United States (APG-2575, Palbociclib)

Recruiting
  • Breast Cancer
  • Solid Tumor, Adult
  • Atlanta, Georgia
  • +3 more
Aug 12, 2022

Hematologic Malignancies Trial in Australia, United States (APG-2575)

Recruiting
  • Hematologic Malignancies
  • APG-2575
  • Jacksonville, Florida
  • +4 more
Aug 12, 2022

T-Prolymphocytic Leukemia Trial in Duarte, Columbus, Houston (APG-115, APG-2575)

Recruiting
  • T-Prolymphocytic Leukemia
  • Duarte, California
  • +2 more
Jul 8, 2022

Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in China (APG-2575)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Lymphoma
  • APG-2575
  • Hefei, Anhui, China
  • +4 more
Feb 23, 2022

Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy Trial in China (APG-2575, reduced-dose HHT, standard-dose HHT)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukaemia
  • Myeloid Malignancy
  • APG-2575
  • +3 more
  • Beijing, Beijing, China
  • +9 more
Jan 10, 2022

Multiple Myeloma Trial in China (APG-2575, Rd)

Recruiting
  • Multiple Myeloma
  • Beijing, Beijing, China
  • +11 more
Feb 20, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (APG-2575, Rituximab, Ibrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • APG-2575
  • +2 more
  • Beijing, Beijing, China
  • +17 more
Sep 2, 2021